Markets Insiderflipped into Markets InsiderInvestingThe Need for Greater Efficacy Drives Increased Switching from Branded TNF Inhibitors to Takeda's Entyvio, Janssen's Stelara, Business Insider - markets.businessinsider.comEXTON, Pa., Sept. 24, 2020 /PRNewswire/ -- The 2020 audit included in Spherix's RealWorld Dynamix™: Biologic/Small Molecule Switching in IBD (US) service focuses on a critical facet of overall biologic...
Markets Insiderflipped into Markets InsiderInvesting Tiziana Life Sciences Interview to Air on Bloomberg International on The RedChip Money Report Business Insider - markets.businessinsider.comLONDON and NEW YORK, Sept. 25, 2020 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics for...
D Rocketusflipped into U.S.A. And World InfoCannabis The Link Between Cannabis And Autoimmune Diseases - The Fresh Toast thefreshtoast.com Scientific evidence regarding the role of the endocannabinoid system in the treatment of autoimmune diseases is just emerging, but cannabis seems to …
Parents Magazineflipped into All StoriesPain The Real Reason Your Stomach Hurts Parents Magazine - Peg Rosen Motherhood and gut problems do not mix well, but they do mix often. Four moms with chronic, confounding symptoms share their rough, relatable …
Icon version of the Flipboard logoGenetics Volume 17 Issue 10, October 2020 nature.com Intestinal epithelial glycosylation is influenced by host genetics, the environment and the gut microbiota. In this Review, Kudelka et al. describe …
Markets Insiderflipped into Markets InsiderClinical Trials Morphic Therapeutic Announces First Healthy Volunteers Dosed in Phase 1 Clinical Trial of MORF-057 Business Insider - markets.businessinsider.comFirst orally available integrin inhibitor from MInT Platform to enter the clinic MORF-057, inhibitor of α4β7 integrin, in development to treat inflammatory bowel disease Phase 1 programto assess safety...
